usa buys10 Jul 2014 13:52
a few more buys now - much of the ABZA work is in the USA - this from todays News article on the ABZA website
"The market which Abzena serves is growing, driven by an increase in outsourcing of R&D by major biopharmaceutical companies, as well as by biotechnology companies looking externally to access expertise and skills. The US market for applied research and preclinical drug development, the areas in which Abzena operates, is estimated at $9.6-$11.5 billion; the majority of Abzena's revenues are derived from providing services and access to its technologies to US customers."